User profiles for Jörg Janne Vehreschild

Jörg Janne Vehreschild

Professor of Digital Medicine und Clinical Data Science, Goethe University Frankfurt …
Verified email at med.uni-frankfurt.de
Cited by 13906

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®

…, MJGT Vehreschild, JJ Vehreschild… - Critical reviews in …, 2019 - Taylor & Francis
Invasive Scedosporium spp. and Lomentospora prolificans infections are an emerging
threat in immunocompromised and occasionally in healthy hosts. Scedosporium spp. is …

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German …

…, S Schwartz, A Ullmann, JJ Vehreschild… - Mycoses, 2018 - Wiley Online Library
Invasive fungal diseases ( IFD ) are a primary cause of morbidity and mortality in patients
with haematological malignancies. These infections are mostly life‐threatening and an early …

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases

M von Lilienfeld-Toal, JJ Vehreschild, O Cornely… - Leukemia, 2020 - nature.com
Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems
worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse …

Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study

…, NE El Mokhtari, M Witzenrath, JJ Vehreschild… - …, 2022 - thelancet.com
Background Post-COVID syndrome (PCS) is an important sequela of COVID-19, characterised
by symptom persistence for >3 months, post-acute symptom development, and worsening …

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

…, S Neumann, O Penack, G Silling, JJ Vehreschild… - Annals of …, 2016 - Springer
Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …

[HTML][HTML] Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the …

…, M Sandherr, M Sieniawski, JJ Vehreschild… - …, 2009 - ncbi.nlm.nih.gov
There is no widely accepted standard for antifungal prophylaxis in patients with hematologic
malignancies. The Infectious Diseases Working Party of the German Society for …

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill… - The lancet HIV, 2017 - thelancet.com
Background Health care for people living with HIV has improved substantially in the past
two decades. Robust estimates of how these improvements have affected prognosis and life …

[HTML][HTML] Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and …

…, JJ Vehreschild, A Candoni, MJGT Vehreschild - …, 2013 - ncbi.nlm.nih.gov
Our case series may have been subject to selection bias, as only those patients who
survived long enough to receive a combination therapy were included. However, since …

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with …

…, B Spiess, WJ Heinz, JJ Vehreschild… - Journal of …, 2012 - academic.oup.com
Objectives Invasive aspergillosis (IA) is a life-threatening infection in severely
immunocompromised patients, especially those receiving intensive chemotherapy or undergoing …

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated …

…, O Penack, F Weißinger, HH Wolf, JJ Vehreschild - Annals of …, 2021 - Springer
Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression
are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (…